IP Library › Granted Patent US 9,968,463
Granted Patent B2
US 9,968,463 · App. 15/227,007 · Granted May 15, 2018

Devices and methods for tissue engineering

Inventor: James Jenq Liu (Mason, OH)
Assignee: BIO2 TECHNOLOGIES, INC.
A61F2/4465A61F2/30734A61L27/10A61L27/54A61L27/56A61L27/58C03C4/0014C03C10/0009C03C13/006A61F2002/30062A61F2002/3092A61F2002/30968A61F2002/4495A61F2310/00329A61L2430/38C03C2204/00C03C2213/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,968,463
App. No.
15/227,007
Granted
May 15, 2018
Kind
B2
Abstract

A resorbable tissue scaffold fabricated from bioactive glass fiber forms a rigid three-dimensional porous matrix having a bioactive composition. Porosity in the form of interconnected pore space is provided by the space between the bioactive glass fiber in the porous matrix. Strength of the bioresorbable matrix is provided by bioactive glass that fuses and bonds the bioactive glass fiber into the rigid three-dimensional matrix. The resorbable tissue scaffold supports tissue in-growth to provide osteoconductivity as a resorbable tissue scaffold, used for the repair of damaged and/or diseased bone tissue.

Claims (10)

1. A spinal implant comprising:

a body having a height sized for engagement within a space between adjacent vertebrae;

the body having a composition that is formed essentially of bioactive glass fibers sintered into a rigid, porous structure having a porosity of 40% to 85%, the porosity having a controlled pore size and a controlled pore size distribution established from a pore former to optimize pore morphology to enhance flow of blood and body fluid within the rigid, porous structure; and

the body adapted to be inserted into the space between adjacent vertebrae wherein body facilitates an ingrowth of tissue to promote fusion and wherein the body is resorbable.

2. The spinal implant according to claim 1 wherein the height is greater than the space between adjacent vertebrae.

3. The spinal implant according to claim 1 wherein the bioactive glass fibers include a crystalline phase.

4. The spinal implant according to claim 1 wherein the bioactive glass fibers have a composition comprising mol % quantities of 6% Na2O; 7.9% K2O; 7.7% MgO; 22.1% CaO; 1.7% P2O5; and 54.6% SiO2.

5. The spinal implant according to claim 1 wherein the body has a porosity that is less than 50% and a compressive strength that is greater than 22 MPa.

6. The spinal implant according to claim 1 wherein the bioactive glass fibers have a plurality of compositions.

7. The spinal implant according to claim 1 wherein the porous structure further comprises bioactive glass coating the bioactive glass fibers.

Assignments (4)
SECURITY INTEREST Recorded Dec 3, 2021
From: NOVUM MEDICAL, INC.
To: DSM VENTURING B.V.
Reel/Frame 058283/0638 →
CHANGE OF NAME Recorded Apr 8, 2021
From: BIO2 TECHNOLOGIES, INC.
To: NOVUM MEDICAL, INC.
Reel/Frame 055872/0900 →
SECURITY INTEREST Recorded Dec 8, 2020
From: BIO2 TECHNOLOGIES, INC.
To: DSM VENTURING B.V.
Reel/Frame 054577/0284 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2018
From: LIU, JAMES J
To: BIO2 TECHNOLOGIES, INC.
Reel/Frame 045563/0300 →
Continuity (5)
Continuation 14180638 · Feb 14, 2014
Continuation 12832394 · Jul 8, 2010
Provisional Application 61234768 · Aug 18, 2009
Provisional Application 61224675 · Jul 10, 2009
Related Publication 20170095351A1 · Apr 6, 2017